Manufacturing Chemist

Breaking News

Takeda's NDA for metastatic colorectal cancer treatment

The NDA for fruquintinib includes results from the Phase III FRESCO-2 trial along with data from the Phase III FRESCO trial conducted in China

Violet Therapeutics raises $10.6m for cell-cell interaction mechanisms

The round was led by the Dementia Discovery Fund (DDF), making its first investment from its latest fund – the Dementia Discovery Fund 2 (DDF-2)

ten23 health releases its 'fairstainability' report

In 2022, ten23 health continued the implementation of plastic recycling in the Basel laboratories and reducing plastic disposables

A future manufacturing setup for Pharma 4.0

Developing autonomous manufacturing processes using benchtop crystallisers

Synexa joins CEPI to "advance global epidemic preparedness"

This strategic partnership represents a significant milestone in Synexa's commitment to global health security

Olon enters ADC market with ultra-potent compound facility

These compounds will be used as payloads and payload-linkers for antibody-drug conjugates (ADCs), one of the most promising emerging cancer therapies

Living in a material world

Mass consumption's rise has led to waste on a previously unimaginable scale. Kathy Illingworth, Head of Sustainability and Consulting at Ecoveritas...

What to consider for successful GMP Annex 1 implementation

In advance of her presentation at Manufacturing Chemist Live, Dr Nicole Hunter (NH), Head of Global Regulatory and Validation Services at Watson-Ma...

Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals

Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers a...

Aurigene expands CDMO facilities for viral vectors

The facility allows for maximum flexibility for a multi-product, multi-platform offering across therapeutic proteins, antibodies, and viral vectors

Accelerating drug discovery with market leading cell line generation

In January 2023, integrated drug discovery company Sygnature Discovery announced the acquisition of SB Drug Discovery, a world-leading provider of...

Highly potent formulation development in oncology

Formulation development is a dynamic and experimental process. However, certain challenges are presented to CDMOs that add a layer of unnecessary p...

Envirotainer celebrates 10 years of Mexican operations

Over the past 10 years, the company has worked closely with its partner, ULD Services MEX, to develop temperature-controlled air freight in the cou...

Network, learn and innovate at the heart of US pharma

Ahead of CPHI North America, Dr Kevin Robinson (KSR) spoke with Sarah Griffin (SG), Brand Manager at Informa, to get her perspectives on what’s new...